iHerb, a prominent online retailer of health products and supplements, is anticipated to launch a $500 million initial public offering (IPO) this year. The company has reportedly chosen financial institutions to manage the offering, signaling a significant step towards becoming a publicly traded entity.
iHerb previously submitted a confidential draft registration statement to the U.S. Securities and Exchange Commission (SEC) in July 2021, indicating its intent for an IPO. At that time, the number of shares to be offered and the price range were yet to be determined. The move aligns with the company's long-term strategic development, which has included strengthening financial rigor and governance.
The health and wellness marketplace, founded in 1996 and based in Irvine, California, has demonstrated strong recent performance. For fiscal year 2025, iHerb announced record net sales of $2.9 billion, a 19% increase year-over-year. The company fulfilled over 44 million orders and served 15 million active customers globally, with approximately 80% of orders coming from repeat customers. They also significantly expanded their global logistics and operational footprint in 2025.
In January 2026, iHerb further expanded its market presence by acquiring Vitacost from The Kroger Co. This acquisition was noted by CFO Mike Cody as a complementary move to enhance scale and broaden customer reach within the U.S., leveraging iHerb's global fulfillment network and technology. The company continues to invest in infrastructure and governance to support sustainable, profitable growth while expanding its offerings and customer engagement through initiatives like the iHerb Wellness Hub.
